Atezolizumab (atezolizumab) is a humanized anti-PD-L1 monoclonal antibody that inhibits PD-L1 signaling with PD-1 and B7-1 and restores tumor-specific T-cell immunity. However, it does not affect the interaction of PD-L2 with PD-1. Atezolizumab reacts with murine PD-L1 (for human and non-humanized mice).
Purity:
>99.0%
CAS Number:
[1380723-44-3]
Target:
PD-1/PD-L1
* VAT and and shipping costs not included. Errors and price changes excepted
